{
  "docId": "019dd923-5fec-763b-95cf-69b322a96f02",
  "docSlug": "xGWB9GQTbCGJgy3pFbHe",
  "documentTitle": "The 24-slide presentation a first-time CEO used to raise $120 million to cure blindness",
  "authorId": "Pitchdecks",
  "authorName": "Aurion Biotech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 2,
  "pageCount": 24,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "disclaimer",
  "function": "front_matter",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": [
    "headline_text",
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95cf-69b322a96f02/2",
  "deckHref": "/decks/019dd923-5fec-763b-95cf-69b322a96f02",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95cf-69b322a96f02.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95cf-69b322a96f02#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.92,
        "x": 0.04,
        "y": 0.23
      },
      "kind": "disclaimer",
      "text": "This presentation and the accompanying oral commentary contain forward-looking statements that involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact could be deemed forward-looking, including, but not limited to, any projections of financial information; any statements about historical results that may suggest trends for our business; any statements of the plans, strategies, and objectives of management for future operations; any statements of expectation of belief regarding future events, potential markets or market size, technology developments, or enforceability of our intellectual property rights; any statements regarding our ability to successfully launch and commercialize new product offerings including Cornea Cell Therapy (CCT) and other products or potential products and the timing thereof; and any statements of assumptions underlying any of the items mentioned.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f395921-0e93-4b02-ab29-32cfb22d2533",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.04,
        "y": 0.51
      },
      "kind": "disclaimer",
      "text": "These statements are based on estimates and information available to us at the time of this presentation and are not guarantees of future performance. Actual results could differ materially from our current expectations as a result of many factors, including, but not limited to, quarterly fluctuations in our business; market acceptance of our offerings; the effects of competition and technological advances on our ability to successfully commercialize our offerings; the regulatory regime for our offerings; and any adverse changes in our strategic relationships, including with licensors of our technologies and manufacturers and distributors of our offerings; and adverse conditions in the general domestic and global economic markets. We assume no obligation and do not intend to update these forward-looking statements or to conform these statements to actual results or to changes in our expectations.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98d139f6-d6bd-4986-9657-540b3f84337e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.76
      },
      "kind": "disclaimer",
      "text": "\"CorneaGen\" the CorneaGen logo, \" Aurion Biotech,\" the Aurion Biotech logo, and \"Vyznova\" and the Vyznova logo are registered trademarks of CorneaGen Inc. in various jurisdictions. All other trademarks belong to their respective owner.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d955ed49-4cc5-4b4c-b534-b5ece5c56292",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "Forward-looking Statements",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a45c3b29-2fde-4102-b5f3-404f8d4cc926",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}